Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 53 entries
View as:

Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza

Phase: N/A Priority: Normal
NCT ID: NCT02369159 Org: User:
Start: 03/11/15 End: 05/14/20 Due: 05/14/21

Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout

Phase: N/A Priority: Normal
NCT ID: NCT01129648 Org: User:
Start: 05/31/10 End: 11/30/10 Due: 11/30/11

A Study of the Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161

Phase: N/A Priority: Normal
NCT ID: NCT02125162 Org: User:
Start: 04/30/14 End: 07/31/14 Due: 07/31/15

Open-label, Long-term Safety Study of Avoralstat in Subjects With Hereditary Angioedema

Phase: N/A Priority: Normal
NCT ID: NCT02670720 Org: User:
Start: 12/31/15 End: 02/29/16 Due: 02/28/17

A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725

Phase: N/A Priority: Normal
NCT ID: NCT06539507 Org: User:
Start: 09/26/24 End: 07/31/25 Due: 07/31/26

A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza

Phase: N/A Priority: Normal
NCT ID: NCT00705406 Org: User:
Start: 07/31/08 End: 10/31/09 Due: 10/31/10

Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza

Phase: N/A Priority: Normal
NCT ID: NCT00957996 Org: User:
Start: 10/31/09 End: 08/31/11 Due: 08/31/12

Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza

Phase: N/A Priority: Normal
NCT ID: NCT00610935 Org: User:
Start: 01/31/08 End: 02/29/08 Due: 02/28/09

Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT00640523 Org: User:
Start: 03/31/08 End: 11/30/11 Due: 11/30/12

A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT03891420 Org: User:
Start: 04/09/20 End: 04/30/21 Due: 04/30/22

A Study of Peldesine (BCX-34) in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002237 Org: User:
Start: - End: - Due: -

Study of BCX7353 as a Treatment for Attacks of Hereditary Angioedema

Phase: N/A Priority: Normal
NCT ID: NCT03240133 Org: User:
Start: 07/31/17 End: 01/29/19 Due: 01/29/20

Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza

Phase: N/A Priority: Normal
NCT ID: NCT00453999 Org: User:
Start: 07/31/07 End: 08/31/09 Due: 08/31/10

Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.

Phase: N/A Priority: Normal
NCT ID: NCT00419263 Org: User:
Start: 01/31/07 End: 09/30/07 Due: 09/30/08

A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT01407874 Org: User:
Start: 09/30/11 End: 07/31/12 Due: 07/31/13

Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)

Phase: N/A Priority: Normal
NCT ID: NCT05162066 Org: User:
Start: 02/18/22 End: 09/23/22 Due: 09/23/23

Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00289562 Org: User:
Start: 09/30/04 End: 12/31/07 Due: 12/31/08

Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE

Phase: N/A Priority: Normal
NCT ID: NCT01984788 Org: User:
Start: 11/30/13 End: 05/31/14 Due: 05/31/15

A Long Term Safety Study of BCX7353 in Hereditary Angioedema

Phase: N/A Priority: Normal
NCT ID: NCT03472040 Org: User:
Start: 02/16/18 End: 04/27/22 Due: 04/27/23

Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT00289549 Org: User:
Start: 06/30/05 End: 01/31/09 Due: 01/31/10

A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza

Phase: N/A Priority: Normal
NCT ID: NCT00958776 Org: User:
Start: 11/30/09 End: 10/31/13 Due: 10/31/14

Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT00035022 Org: User:
Start: 08/31/01 End: 03/31/04 Due: 03/31/05

BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00061880 Org: User:
Start: 02/28/03 End: 01/31/08 Due: 01/31/09

Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00095381 Org: User:
Start: 03/31/04 End: 12/31/07 Due: 12/31/08

An Open-label Drug-Drug Interaction Study to Evaluate the Effect of BCX7353 on Cytochrome P450 Enzyme Activity Using Probe Substrates

Phase: N/A Priority: Normal
NCT ID: NCT02819102 Org: User:
Start: 03/31/16 End: 06/30/16 Due: 06/30/17